ADVERTISEMENT

Naureen Starling, MBBS, MD

O-002: Ibrutinib in Combination With Nab-Paclitaxel and Gemcitabine as First-Line Treatment for Patients With Metastatic Pancreatic Adenocarcinoma: Results From the Phase 3 RESOLVE Study

Access the abstract

Jean-Baptiste Bachet ;

Heung-Moon Chang ;

Lisa M. Coussens ;

Lawrence Fong ;

L. Claire Tsao ;

George Cole Jr.;

Danelle James ;

Eric Van Cutsem , MD, PhD;

Margaret A. Tempero , MD;

Teresa Macarulla , MD, PhD;

Josep Tabernero , MD, PhD;

Andrew Hendifar ;

Naureen Starling , MBBS, MD;

Dirk-Thomas Waldschmidt ;

07/31/2019

Analysis of the immune-related endpoints of the mismatch repair–deficient non-endometrial solid cancers cohort from the GARNET study

Background Dostarlimab is a humanized monoclonal antibody that binds the programmed cell death protein 1 (PD-1) receptor and blocks interaction with its ligands PD-L1 and PD-L2. The GARNE...

G. Curigliano ;

Naureen Starling , MBBS, MD;

07/01/2021

Pathological primary tumour and lymph node regression following neoadjuvant chemotherapy in resectable oesophagogastric cancer: Pooled analysis of 1619 patients from two randomised trials

Background No definitive largescale data exists evaluating the role of pathologically defined regression changes within lymph nodes (LN) of resected oesophagogastric (OG) adenocarcinoma ...

Naureen Starling , MBBS, MD;

David Cunningham ;

06/30/2022

Immunotherapy for GI Cancers in the Elderly

Naureen Starling , MBBS, MD;

07/07/2023

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

See Full Calendar

Advertisement

Advertisement